Pharma Journalist -

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory…
Read More...

SMi reports: Uncover the latest innovations in combination product development at Pre-filled Syringes West Coast 2021 The 5th annual conference promises to be even bigger and will…
Read More...

Thermo Fisher Scientific Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the Thermo Fisher Scientific Amplitude…
Read More...

Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class…
Read More...

CanSino Biologics Inc. announced that the Instituto de Salud Pública de Chile granted emergency use authorization for its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5…
Read More...

Biogen Inc. and Bio-Thera Solutions, Ltd. announced that they entered into a commercialization and license agreement to develop, manufacture and commercialize BAT1806, a Phase 3…
Read More...

Sanofi acquired Tidal Therapeutics, a privately owned, pre-clinical stage biotech company with a novel mRNA-based approach for in vivo reprogramming of immune cells. The new technology…
Read More...

SMi Group Reports: Key topics such as Occupational Toxicology and Placing Worker Safety at the Forefront to be discussed at SMi’s 5th Annual HPAPi Virtual Conference, on 10-11 May 2021.…
Read More...

SMi Group Reports: Achim Kless, Pain Genetics Lead from Eli Lilly & Company gives an exclusive interview ahead of SMi’s 21st Annual Pain Therapeutics Virtual Conference, taking…
Read More...

Celcuity Inc. a clinical-stage biotechnology company pursuing an integrated companion diagnostic and therapeutic strategy for treating patients with cancer, announced it has entered…
Read More...